Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1997 Jun;71(6):4425–4435. doi: 10.1128/jvi.71.6.4425-4435.1997

In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles.

S Campbell 1, V M Vogt 1
PMCID: PMC191661  PMID: 9151833

Abstract

Retroviruses are unusual in that expression of a single protein, Gag, leads to budding of virus-like particles into the extracellular space. We have developed conditions under which virus-like particles are formed spontaneously in vitro from fragments of Rous sarcoma virus (RSV) Gag protein purified after expression in Escherichia coli. The CA-NC fragment of Gag was shown previously to assemble into hollow cylinders (S. Campbell and V. M. Vogt, J. Virol. 69:6487-6497, 1995). We have now extended these studies to larger Gag proteins. In every case examined, assembly into regular structures required RNA. A nearly full-length Gag missing only the C-terminal PR domain, as well as similar proteins missing in addition the N-terminal half of MA, the C-terminal half of MA, the entire MA sequence, or the entire p2 sequence, all assembled into spherical particles resembling RSV in size. By contrast, proteins missing p10 assembled into cylindrical particles like those formed by CA-NC alone. Thin section electron microscopy showed that each of these Gag proteins formed in the expressing E. coli cells particles similar in shape to those seen in vitro. We conclude from these results that neither the sequences required for membrane binding in vivo, near the N terminus of Gag, nor the sequences required for a late step in budding, in the p2 portion of Gag, are essential for formation of virus-like particles in this system. Furthermore, we postulate the existence of a shape-determining sequence in p10, which provides or facilitates interactions required for the growing particle to be constrained to a spherical shape.

Full Text

The Full Text of this article is available as a PDF (2.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. J., Stone J., Lum R., Linial M. L. The packaging phenotype of the SE21Q1b provirus is related to high proviral expression and not trans-acting factors. J Virol. 1995 Nov;69(11):7319–7323. doi: 10.1128/jvi.69.11.7319-7323.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bennett R. P., Nelle T. D., Wills J. W. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins. J Virol. 1993 Nov;67(11):6487–6498. doi: 10.1128/jvi.67.11.6487-6498.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berkowitz R. D., Ohagen A., Höglund S., Goff S. P. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo. J Virol. 1995 Oct;69(10):6445–6456. doi: 10.1128/jvi.69.10.6445-6456.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Campbell S., Vogt V. M. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J Virol. 1995 Oct;69(10):6487–6497. doi: 10.1128/jvi.69.10.6487-6497.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. De-Thé G., O'Connor T. E. Structure of a murine leukemia virus after disruption with tween-ether and comparison with two myxoviruses. Virology. 1966 Apr;28(4):713–728. doi: 10.1016/0042-6822(66)90256-x. [DOI] [PubMed] [Google Scholar]
  6. Delchambre M., Gheysen D., Thines D., Thiriart C., Jacobs E., Verdin E., Horth M., Burny A., Bex F. The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J. 1989 Sep;8(9):2653–2660. doi: 10.1002/j.1460-2075.1989.tb08405.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dupraz P., Spahr P. F. Analysis of deletions and thermosensitive mutations in Rous sarcoma virus gag protein p10. J Virol. 1993 Jul;67(7):3826–3834. doi: 10.1128/jvi.67.7.3826-3834.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dupraz P., Spahr P. F. Specificity of Rous sarcoma virus nucleocapsid protein in genomic RNA packaging. J Virol. 1992 Aug;66(8):4662–4670. doi: 10.1128/jvi.66.8.4662-4670.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fäcke M., Janetzko A., Shoeman R. L., Kräusslich H. G. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J Virol. 1993 Aug;67(8):4972–4980. doi: 10.1128/jvi.67.8.4972-4980.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gheysen D., Jacobs E., de Foresta F., Thiriart C., Francotte M., Thines D., De Wilde M. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell. 1989 Oct 6;59(1):103–112. doi: 10.1016/0092-8674(89)90873-8. [DOI] [PubMed] [Google Scholar]
  11. Gorelick R. J., Chabot D. J., Rein A., Henderson L. E., Arthur L. O. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J Virol. 1993 Jul;67(7):4027–4036. doi: 10.1128/jvi.67.7.4027-4036.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gorelick R. J., Henderson L. E., Hanser J. P., Rein A. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc Natl Acad Sci U S A. 1988 Nov;85(22):8420–8424. doi: 10.1073/pnas.85.22.8420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gorelick R. J., Nigida S. M., Jr, Bess J. W., Jr, Arthur L. O., Henderson L. E., Rein A. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J Virol. 1990 Jul;64(7):3207–3211. doi: 10.1128/jvi.64.7.3207-3211.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hockley D. J., Nermut M. V., Grief C., Jowett J. B., Jones I. M. Comparative morphology of Gag protein structures produced by mutants of the gag gene of human immunodeficiency virus type 1. J Gen Virol. 1994 Nov;75(Pt 11):2985–2997. doi: 10.1099/0022-1317-75-11-2985. [DOI] [PubMed] [Google Scholar]
  15. Hockley D. J., Wood R. D., Jacobs J. P., Garrett A. J. Electron microscopy of human immunodeficiency virus. J Gen Virol. 1988 Oct;69(Pt 10):2455–2469. doi: 10.1099/0022-1317-69-10-2455. [DOI] [PubMed] [Google Scholar]
  16. Hwang D. J., Roberts I. M., Wilson T. M. Expression of tobacco mosaic virus coat protein and assembly of pseudovirus particles in Escherichia coli. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9067–9071. doi: 10.1073/pnas.91.19.9067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Klikova M., Rhee S. S., Hunter E., Ruml T. Efficient in vivo and in vitro assembly of retroviral capsids from Gag precursor proteins expressed in bacteria. J Virol. 1995 Feb;69(2):1093–1098. doi: 10.1128/jvi.69.2.1093-1098.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kuff E. L., Lueders K. K. The intracisternal A-particle gene family: structure and functional aspects. Adv Cancer Res. 1988;51:183–276. doi: 10.1016/s0065-230x(08)60223-7. [DOI] [PubMed] [Google Scholar]
  19. Levin J. G., Grimley P. M., Ramseur J. M., Berezesky I. K. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J Virol. 1974 Jul;14(1):152–161. doi: 10.1128/jvi.14.1.152-161.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Linial M. L., Miller A. D. Retroviral RNA packaging: sequence requirements and implications. Curr Top Microbiol Immunol. 1990;157:125–152. doi: 10.1007/978-3-642-75218-6_5. [DOI] [PubMed] [Google Scholar]
  21. Linial M., Medeiros E., Hayward W. S. An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization. Cell. 1978 Dec;15(4):1371–1381. doi: 10.1016/0092-8674(78)90062-4. [DOI] [PubMed] [Google Scholar]
  22. Luftig R. B., Yoshinaka Y. Rauscher leukemia virus populations enriched for "immature" virions contain increased amounts of P70, the gag gene product. J Virol. 1978 Jan;25(1):416–421. doi: 10.1128/jvi.25.1.416-421.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Menéndez-Arias L., Risco C., Pinto da Silva P., Oroszlan S. Purification of immature cores of mouse mammary tumor virus and immunolocalization of protein domains. J Virol. 1992 Sep;66(9):5615–5620. doi: 10.1128/jvi.66.9.5615-5620.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Morikawa Y., Hinata S., Tomoda H., Goto T., Nakai M., Aizawa C., Tanaka H., Omura S. Complete inhibition of human immunodeficiency virus Gag myristoylation is necessary for inhibition of particle budding. J Biol Chem. 1996 Feb 2;271(5):2868–2873. doi: 10.1074/jbc.271.5.2868. [DOI] [PubMed] [Google Scholar]
  25. Nelle T. D., Wills J. W. A large region within the Rous sarcoma virus matrix protein is dispensable for budding and infectivity. J Virol. 1996 Apr;70(4):2269–2276. doi: 10.1128/jvi.70.4.2269-2276.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nermut M. V., Frank H., Schäfer W. Properties of mouse leukemia viruses. 3. Electron microscopic appearance as revealed after conventional preparation techniques as well as freeze-drying and freeze-etching. Virology. 1972 Aug;49(2):345–358. doi: 10.1016/0042-6822(72)90487-4. [DOI] [PubMed] [Google Scholar]
  27. Nermut M. V., Grief C., Hashmi S., Hockley D. J. Further evidence of icosahedral symmetry in human and simian immunodeficiency virus. AIDS Res Hum Retroviruses. 1993 Oct;9(10):929–938. doi: 10.1089/aid.1993.9.929. [DOI] [PubMed] [Google Scholar]
  28. Nermut M. V., Hockley D. J., Jowett J. B., Jones I. M., Garreau M., Thomas D. Fullerene-like organization of HIV gag-protein shell in virus-like particles produced by recombinant baculovirus. Virology. 1994 Jan;198(1):288–296. doi: 10.1006/viro.1994.1032. [DOI] [PubMed] [Google Scholar]
  29. Parent L. J., Bennett R. P., Craven R. C., Nelle T. D., Krishna N. K., Bowzard J. B., Wilson C. B., Puffer B. A., Montelaro R. C., Wills J. W. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J Virol. 1995 Sep;69(9):5455–5460. doi: 10.1128/jvi.69.9.5455-5460.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Park J., Morrow C. D. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles. J Virol. 1992 Nov;66(11):6304–6313. doi: 10.1128/jvi.66.11.6304-6313.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Pepinsky R. B., Papayannopoulos I. A., Campbell S., Vogt V. M. Analysis of Rous sarcoma virus Gag protein by mass spectrometry indicates trimming by host exopeptidase. J Virol. 1996 May;70(5):3313–3318. doi: 10.1128/jvi.70.5.3313-3318.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Pepinsky R. B., Vogt V. M. Purification and properties of a fifth major viral gag protein from avian sarcoma and leukemia viruses. J Virol. 1983 Feb;45(2):648–658. doi: 10.1128/jvi.45.2.648-658.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Pognonec P., Kato H., Sumimoto H., Kretzschmar M., Roeder R. G. A quick procedure for purification of functional recombinant proteins over-expressed in E.coli. Nucleic Acids Res. 1991 Dec 11;19(23):6650–6650. doi: 10.1093/nar/19.23.6650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rasmussen L., Battles J. K., Ennis W. H., Nagashima K., Gonda M. A. Characterization of virus-like particles produced by a recombinant baculovirus containing the gag gene of the bovine immunodeficiency-like virus. Virology. 1990 Oct;178(2):435–451. doi: 10.1016/0042-6822(90)90341-n. [DOI] [PubMed] [Google Scholar]
  35. Rein A., Harvin D. P., Mirro J., Ernst S. M., Gorelick R. J. Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus. J Virol. 1994 Sep;68(9):6124–6129. doi: 10.1128/jvi.68.9.6124-6129.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rhee S. S., Hunter E. A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell. 1990 Oct 5;63(1):77–86. doi: 10.1016/0092-8674(90)90289-q. [DOI] [PubMed] [Google Scholar]
  37. Rhee S. S., Hunter E. Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids. J Virol. 1987 Apr;61(4):1045–1053. doi: 10.1128/jvi.61.4.1045-1053.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Royer M., Cerutti M., Gay B., Hong S. S., Devauchelle G., Boulanger P. Functional domains of HIV-1 gag-polyprotein expressed in baculovirus-infected cells. Virology. 1991 Sep;184(1):417–422. doi: 10.1016/0042-6822(91)90861-5. [DOI] [PubMed] [Google Scholar]
  39. Sakalian M., Parker S. D., Weldon R. A., Jr, Hunter E. Synthesis and assembly of retrovirus Gag precursors into immature capsids in vitro. J Virol. 1996 Jun;70(6):3706–3715. doi: 10.1128/jvi.70.6.3706-3715.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sakalian M., Wills J. W., Vogt V. M. Efficiency and selectivity of RNA packaging by Rous sarcoma virus Gag deletion mutants. J Virol. 1994 Sep;68(9):5969–5981. doi: 10.1128/jvi.68.9.5969-5981.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sarkar N. H., Nowinski R. C., Moore D. H. Helical nucleocapsid structure of the oncogenic ribonucleic acid viruses (oncornaviruses). J Virol. 1971 Oct;8(4):564–572. doi: 10.1128/jvi.8.4.564-572.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Schultz A. M., Rein A. Unmyristylated Moloney murine leukemia virus Pr65gag is excluded from virus assembly and maturation events. J Virol. 1989 May;63(5):2370–2373. doi: 10.1128/jvi.63.5.2370-2373.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Schwartz D. E., Tizard R., Gilbert W. Nucleotide sequence of Rous sarcoma virus. Cell. 1983 Mar;32(3):853–869. doi: 10.1016/0092-8674(83)90071-5. [DOI] [PubMed] [Google Scholar]
  44. Spearman P., Ratner L. Human immunodeficiency virus type 1 capsid formation in reticulocyte lysates. J Virol. 1996 Nov;70(11):8187–8194. doi: 10.1128/jvi.70.11.8187-8194.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Spearman P., Wang J. J., Vander Heyden N., Ratner L. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J Virol. 1994 May;68(5):3232–3242. doi: 10.1128/jvi.68.5.3232-3242.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Steeg C. M., Vogt V. M. RNA-binding properties of the matrix protein (p19gag) of avian sarcoma and leukemia viruses. J Virol. 1990 Feb;64(2):847–855. doi: 10.1128/jvi.64.2.847-855.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Stewart L., Schatz G., Vogt V. M. Properties of avian retrovirus particles defective in viral protease. J Virol. 1990 Oct;64(10):5076–5092. doi: 10.1128/jvi.64.10.5076-5092.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Stewart L., Vogt V. M. trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase. J Virol. 1991 Nov;65(11):6218–6231. doi: 10.1128/jvi.65.11.6218-6231.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Studier F. W., Moffatt B. A. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol. 1986 May 5;189(1):113–130. doi: 10.1016/0022-2836(86)90385-2. [DOI] [PubMed] [Google Scholar]
  50. Studier F. W., Rosenberg A. H., Dunn J. J., Dubendorff J. W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 1990;185:60–89. doi: 10.1016/0076-6879(90)85008-c. [DOI] [PubMed] [Google Scholar]
  51. Weldon R. A., Jr, Erdie C. R., Oliver M. G., Wills J. W. Incorporation of chimeric gag protein into retroviral particles. J Virol. 1990 Sep;64(9):4169–4179. doi: 10.1128/jvi.64.9.4169-4179.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Weldon R. A., Jr, Wills J. W. Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release. J Virol. 1993 Sep;67(9):5550–5561. doi: 10.1128/jvi.67.9.5550-5561.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Wills J. W., Cameron C. E., Wilson C. B., Xiang Y., Bennett R. P., Leis J. An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol. 1994 Oct;68(10):6605–6618. doi: 10.1128/jvi.68.10.6605-6618.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wills J. W., Craven R. C. Form, function, and use of retroviral gag proteins. AIDS. 1991 Jun;5(6):639–654. doi: 10.1097/00002030-199106000-00002. [DOI] [PubMed] [Google Scholar]
  55. Wills J. W., Craven R. C., Weldon R. A., Jr, Nelle T. D., Erdie C. R. Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src. J Virol. 1991 Jul;65(7):3804–3812. doi: 10.1128/jvi.65.7.3804-3812.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Yang W., Guo J., Ying Z., Hua S., Dong W., Chen H. Capsid assembly and involved function analysis of twelve core protein mutants of duck hepatitis B virus. J Virol. 1994 Jan;68(1):338–345. doi: 10.1128/jvi.68.1.338-345.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Yuan X., Yu X., Lee T. H., Essex M. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J Virol. 1993 Nov;67(11):6387–6394. doi: 10.1128/jvi.67.11.6387-6394.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Zhang Y., Barklis E. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation. J Virol. 1995 Sep;69(9):5716–5722. doi: 10.1128/jvi.69.9.5716-5722.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Zhou W., Parent L. J., Wills J. W., Resh M. D. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J Virol. 1994 Apr;68(4):2556–2569. doi: 10.1128/jvi.68.4.2556-2569.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES